Amy A. Lubik
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Cancer Research top 5%
- Endocrinology, Diabetes and Metabolism top 5%
- Genetics
- Co-authors
- Colleen C. NelsonHans AdomatMartin GleaveStephen C. HendyJennifer A. LockeSusan EttingerEmma S. Tomlinson GunsCatherine A. Wood
- Topics
- Prostate Cancer Treatment and Research (11 papers)Cancer, Lipids, and Metabolism (7 papers)Metabolism, Diabetes, and Cancer (4 papers)
- Partner nations
- CanadaAustraliaUnited States
In The Last Decade
Amy A. Lubik
15 papers receiving 947 citations
Hit Papers
Peers
Comparison fields: 5 of 73
- Pulmonary and Respiratory Medicine 642
- Molecular Biology 381
- Cancer Research 331
- Endocrinology, Diabetes and Metabolism 286
- Genetics 166
Countries citing papers authored by Amy A. Lubik
This map shows the geographic impact of Amy A. Lubik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy A. Lubik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy A. Lubik more than expected).
Fields of papers citing papers by Amy A. Lubik
This network shows the impact of papers produced by Amy A. Lubik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy A. Lubik. The network helps show where Amy A. Lubik may publish in the future.
Co-authorship network of co-authors of Amy A. Lubik
This figure shows the co-authorship network connecting the top 25 collaborators of Amy A. Lubik. A scholar is included among the top collaborators of Amy A. Lubik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy A. Lubik. Amy A. Lubik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 29 | |
| 2 | 24 | |
| 3 | 30 | |
| 4 | 30 | |
| 5 | 7 | |
| 6 | 42 | |
| 7 | 21 | |
| 8 | 18 | |
| 9 | 18 | |
| 10 | 91 | |
| 11 | Insulin increases De Novo Steroidogenesis in prostate cancer cells | 3 |
| 12 | 64 | |
| 13 | 1 | |
| 14 | 2 | |
| 15 | Androgen Levels Increase by Intratumoral De novo Steroidogenesis during Progression of Castration-Resistant Prostate Cancerbreakdown → | 589 |
About Amy A. Lubik
Amy A. Lubik is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism, having authored 15 papers that have together received 969 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (11 papers), Cancer, Lipids, and Metabolism (7 papers) and Metabolism, Diabetes, and Cancer (4 papers). The work is most often cited by research in Cancer Research (331 citations), Pulmonary and Respiratory Medicine (642 citations) and Endocrinology, Diabetes and Metabolism (286 citations). Amy A. Lubik has collaborated with scholars based in Canada, Australia and United States. Frequent co-authors include Colleen C. Nelson, Hans Adomat, Martin Gleave, Stephen C. Hendy, Jennifer A. Locke, Susan Ettinger, Emma S. Tomlinson Guns, Catherine A. Wood, Jennifer H. Gunter and Michaël Pollak. Their work appears in journals such as Cancer Research, Oncogene and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.